We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.31B
AUM Growth
-$186M
Cap. Flow
-$183M
Cap. Flow %
-3.46%
Top 10 Hldgs %
19.09%
Holding
839
New
96
Increased
271
Reduced
217
Closed
105

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$58.6M
2
BIIB icon
Biogen
BIIB
+$40.7M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$29.8M
4
BIDU icon
Baidu
BIDU
+$27.4M
5
AAPL icon
Apple
AAPL
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 14.94%
2 Industrials 14.89%
3 Financials 13.29%
4 Energy 11.49%
5 Consumer Discretionary 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSTC
351
DELISTED
BioSpecifics Technologies Corp.
BSTC
$595K 0.01%
16,869
+2,933
+21% +$86.1K
DORM icon
352
Dorman Products
DORM
$4.01B
$592K 0.01%
14,766
-54,780
-79% -$2.45M
SSO icon
353
ProShares Ultra S&P500
SSO
$7.82B
$590K 0.01%
80,208
LOW icon
354
Lowe's Companies
LOW
$116B
$581K 0.01%
10,977
-3,188
-23% -$161K
ERF
355
DELISTED
Enerplus Corporation
ERF
$578K 0.01%
30,460
-4,964
-14% -$109K
CLA.CL
356
DELISTED
Capitala Finance Corp.
CLA.CL
$578K 0.01%
22,800
+2,000
+10% +$50.7K
RRC icon
357
Range Resources
RRC
$9.11B
$576K 0.01%
8,490
+70
+0.8% +$5.34K
ETP
358
DELISTED
Energy Transfer Partners L.p.
ETP
$557K 0.01%
8,707
+477
+6% +$27.6K
ISRG icon
359
Intuitive Surgical
ISRG
$121B
$556K 0.01%
10,836
-1,152
-10% -$57.2K
LNT icon
360
Alliant Energy
LNT
$19.4B
$553K 0.01%
19,950
+1,076
+6% +$31K
LDRH
361
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$548K 0.01%
+17,617
New +$456K
OGS icon
362
ONE Gas
OGS
$5.05B
$542K 0.01%
15,832
+2,496
+19% +$91.4K
BPL
363
DELISTED
Buckeye Partners, L.P.
BPL
$538K 0.01%
6,759
-345
-5% -$27.5K
BABA icon
364
Alibaba
BABA
$269B
$531K 0.01%
+5,975
New +$537K
INVX
365
Innovex International
INVX
$1.87B
$531K 0.01%
5,935
+1,105
+23% +$110K
UL icon
366
Unilever
UL
$131B
$529K 0.01%
11,229
-146
-1% -$7.21K
VIG icon
367
Vanguard Dividend Appreciation ETF
VIG
$111B
$529K 0.01%
6,875
-621
-8% -$48.2K
USB.PRN.CL
368
DELISTED
U.S. Bancorp
USB.PRN.CL
$528K 0.01%
19,555
VEA icon
369
Vanguard FTSE Developed Markets ETF
VEA
$226B
$522K 0.01%
13,124
+5,656
+76% +$235K
ATI icon
370
ATI
ATI
$27B
$517K 0.01%
13,925
+3,330
+31% +$140K
FMBI
371
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$514K 0.01%
31,946
ADM icon
372
Archer Daniels Midland
ADM
$41.4B
$508K 0.01%
+9,936
New +$487K
CSX icon
373
CSX Corp
CSX
$98.6B
$507K 0.01%
47,406
+9,000
+23% +$92.8K
AMLP icon
374
Alerian MLP ETF
AMLP
$13B
$502K 0.01%
5,237
-304
-5% -$28.8K
ENH.PRA
375
DELISTED
ENDURANCE SPECIALTY HOLDINGS LTD PFD SER A
ENH.PRA
$501K 0.01%
19,200

Similar funds

Geneva Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Geneva Advisors held 839 positions worth $5.31B, down 3.4% from $5.49B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneva Advisors withdrew a net $183M in Q3 2014, closing 105 positions and reducing 217 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $24.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.

Against the trend, Geneva Advisors opened a new position in Discovery, Inc. Series C Common Stock worth $27.5M.

  • Geneva Advisors's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 736,897 shares worth $27.5M.
  • Geneva Advisors added most to AbbVie in Q3 2014, an estimated $58.6M increase.
  • Geneva Advisors's biggest Q3 2014 reduction was Warner Bros, cutting an estimated $62.3M.
  • Geneva Advisors fully exited ASPEN TECHNOLOGY INC in Q3 2014, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 19% of its $5.31B portfolio in Q3 2014.
  • Geneva Advisors opened 96 new positions and closed 105 in Q3 2014.
  • Geneva Advisors's portfolio value fell 3.4% quarter-over-quarter to $5.31B.

Based on Geneva Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.